REFERENCES
- Artursson P. Cell cultures as models for drug absorption across the intestinal mucosa. Therap. Drug Carrier Sys. 1991; 8: 305–330
- Birnbaum D. T., Kosmala J. D., Henthom D. B., Peppas L. B. Controlled release of β estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. J. Cont. Rel. 2000; 65: 375–387, [CROSSREF]
- Camenisch G., Folkers G., Waterbeemd H. Comparison of passive drug transport through Caco-2 cells and artificial membranes. Int. J. Pharm. 1997; 147: 61–70, [CROSSREF]
- Caro I., Boulenc X., Rousset M., Meunier V., Bourrié M., Julian B., Joyeux H., Roques C., Berger Y., Zweibaum A., Fabre G. Characterisation of a newly isolated caco 2 clone(TC-7), as a model of transport processes and biotransformation of drugs. Int. J. Pharmaceuts. 1995; 116: 147–158, [CROSSREF]
- Castewllanos I. J., Carrasquillo K. G., Lopez J. J., Alvarez M., Griebenow K. Encapsulation of bovine serum albumin in poly(lactide-coglycolide) microspheres by the solid in on in water technique. J. Pharm. Pharmacol. 2000; 53: 167–178, [CROSSREF]
- Değim Z., Ünal N., Abbasoğlu U. Caco-2 cell culture as a model for famotidine and insuline absorption across the intestinal mucosa. World Congress of Pharmacy and Pharmaceutical Sciences. 61st International Congress of FIP, Singapore 2001, Abstracts, 53
- Değim Z., Ağabeyoğlu İ. Nonisothermal stability tests of famotidine and nizatidine. Il Farmaco 2002; 57: 729–735, [CROSSREF]
- Desai M. P., Labhasetwar V., Walter E., Levy R. J., Amidon G. L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 1997; 14: 1568–1573, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Desai M. P., Labhasetwar V., Amidon G. L., Levy R. J. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharm. Res. 1996; 13(12)1838–1845, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Foster K. A., Yazdenian M., Audus K. L. Microparticulate uptake mechanisms of in vitro cell culture models of the respiratory epithelium. J. Pharm. Pharmacol. 2001; 53: 57–66, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gan L. L., Yanni S., Thakker D. R. Modulation of the tight junctions of the Caco-2 cell monolayers by H2-antagonists. Pharm. Res. 1998; 15: 53–57, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Greenwood R., Al-Achi A. Human insulin diffusion profile through a layer of caco 2 cells. Drug Dev. Ind. Pharm. 1997; 23: 221–224
- Hovgaard L., Brondsted H., Nielsen H. M. Drug delivery studies in caco-2 monolayers. II. absorption enhancer effects of lysophosphatdylcholines. Int. J. Pharm. 1995; 114: 141–149, [CROSSREF]
- Kim T. K., Burgess D. J. Formulation and release characteristics of poly(lactic-cc glycolic acid) microspheres containing chemically modified protein. J. Pharm. Pharmacol. 2001; 53: 23–31, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lentz K. A., Hayashi J., Lucisano L. J., Polli J. E. Development of a more rapid, reduced serum culture system for caco-2 monolayers and application to the biopharmaceutics classication system. Int. J. Pharmaceut. 2000; 200: 41–51, [CROSSREF]
- O'leary G., Değim Z., Gumbleton M., Mcguigan C. Permeability of caco-2 novel d4t-monophosphate prodrugs. Eur. J. Pharmaceuti. Sci. 1996, 4: S194
- Tanaka Y., Taki Y., Sakane T., Tanekazu N., Sezaki H., Yamashita S. Characterization of drug transport through tight-juntional pathway in caco-2 monolayer: comparison with isolated rat jejenum and colon. Pharmaceut. Res. 1995; 12: 523–528, [CROSSREF]
- Tunçay M., Çaliş S., Kaş H. S., Ercan M. T., Peksoy İ., Hincal A. Diclofena sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. Int. J. Pharm. 2000; 195: 179–188, [CROSSREF]
- Vanrell R. H., Refojo M. F. Biodegradable microspheres for vitreoretinal drudelivery. Adv Drug Del. Rev. 2001; 52: 5–16, [CROSSREF]